Medical Devices

A new study reveals albumin, the most abundant protein in blood, is a powerful weapon against mucormycosis, offering new hope for treating this fatal infection.

Myra Vision's Calibreye system, the first adjustable glaucoma shunt, has been implanted in a US patient, offering hope for personalized vision-saving therapy.

The acquisition strengthens the independent distributor's hold on the booming plasma therapy market, promising wider access to critical, complex medications.

A new study confirms AI can detect major heart conditions from one brief ultrasound clip, empowering any clinician to perform life-saving cardiac screening.

Avant Technologies is evaluating a therapy to protect insulin cells from immune attack, a breakthrough that could end the need for harsh drugs.

Baird Medical partners with Stonewood Key Capital, using China's Hainan Free Trade Port to accelerate its global push for minimally invasive therapies.

A first-in-class oral therapy targeting cellular metabolism has entered patient trials, offering new hope for a disease-modifying treatment for eczema.

A new intelligent oral appliance using biofeedback shows a massive reduction in sleep bruxism, offering hope to millions who suffer from jaw pain and headaches.

Medical device maker Nuwellis appoints two new directors and sees three resign, a move tied directly to a critical upcoming $5 million equity investment.

With a year of consistent earnings beats and strategic product launches behind it, Enovis is set to reveal its full 2025 results. Here’s what’s at stake.

New 24-month clinical data shows Nalu's tiny neurostimulator provides sustained pain relief and improved function, setting a new bar for chronic pain tech.

Acrivon Therapeutics to unveil pivotal data showing high response rates for its targeted drug ACR-368 in an aggressive endometrial cancer subtype.

Ontario's new FAST program provides accelerated funding for two key cancer drugs, cutting patient wait times and setting a new standard for access in Canada.

A single patient with a debilitating eye pain condition gains access to an investigational therapy, offering hope where no approved treatments exist.

Ozelle will debut an AI system at WHX Labs Dubai that merges three lab functions into one, promising faster, smarter diagnostics for local clinics.

A new in-house lab in Antalya promises international patients faster, more precise dental restorations with unprecedented customization and quality control.

As Embecta prepares its Q1 results, investors watch closely to see if its move beyond insulin can reverse recent revenue declines and reshape its future.

A new strategic partnership aims to dismantle commercialization hurdles, promising faster access to life-saving therapies for rare disease patients.

SPR Therapeutics unveils 12-month data at NANS 2026, showing its temporary SPRINT PNS system provides durable pain relief without a permanent implant.

U.S. firm Catheter Precision secures its first German order for the LockeT device, a strategic move into Europe's largest and most innovative healthcare market.